Skip to main content
Back to Articles
Arthrosamid Injection

Arthrosamid and Joint Infection Risk: What the Evidence Says

11 min read
Translucent 3D illustration of knee joint anatomy with bones and inflamed connective tissue highlighted in orange

✅ Medically reviewed | Updated July 2026

Knee pain researchers eventually land on the same worry: if a hydrogel stays in the joint for years, what happens if it gets infected? This is a fair question, and it deserves a straight answer rather than a marketing brush-off. Most pages covering Arthrosamid and joint infection either bury the risk in fine print or swing the other way and make it sound frightening. Neither approach helps a patient decide anything. This article lays out what the evidence actually says, what UK clinics do to reduce the risk, and how a patient can ask the right questions before booking a single injection.

Why Infection Concerns Patients More With Arthrosamid

Steroid and hyaluronic acid injections break down in the body over weeks or months. Arthrosamid does not. It is a non-biodegradable hydrogel, made of 97.5% water and 2.5% cross-linked polyacrylamide, and it integrates permanently with the synovial membrane inside the knee. That permanence is exactly why patients ask harder questions about infection than they would with a short-term jab.

If bacteria enter a joint that contains a biodegradable filler, the body clears the filler along with the infection over time. A non-biodegradable material behaves differently, so clinicians take joint infection seriously with any long-acting injectable, and Arthrosamid is no exception.

How Common Is Joint Infection After Arthrosamid?

Infection following intra-articular injection is rare across the board, not unique to Arthrosamid. It is classed as a less common but serious risk, alongside hypersensitivity reactions to polyacrylamide. It is not classed as a common side effect like mild swelling, temporary stiffness, or bruising, which settle on their own within days.

Rare does not mean impossible, and clinicians should never suggest otherwise. Any invasive joint procedure — steroid injections, hyaluronic acid, PRP, or Arthrosamid — carries some infection risk because the needle briefly breaches the joint’s natural barrier.

How Arthrosamid Works

Understanding the mechanism explains why sterile technique matters so much here. After a doctor applies local anaesthetic, the hydrogel goes directly into the synovial cavity under ultrasound guidance, usually as an outpatient procedure. Once inside the joint, the hydrogel disperses through the synovial fluid and is gradually taken up into the synovial membrane through the joint’s natural filtering process. This uptake is largely complete within four to six weeks.

As the hydrogel settles into the tissue, it may increase tissue elasticity and resilience, which appears to support symptom relief and improved movement over time, although researchers are still studying the exact pathways. Because the material is non-biodegradable, published follow-up studies report sustained improvements in pain and function for up to five years after a single injection, though outcomes vary between individuals.

Why the Injection Technique Matters for Infection Risk

Every step of that mechanism happens inside a closed joint space. A clean needle pass matters more here than with almost any other injectable, because the hydrogel will sit in that joint for years, not weeks. This is why official product instructions state that clinicians should give prophylactic antibiotics before the injection, and why sterile single-use equipment and a controlled clinical environment are non-negotiable parts of the procedure.

The Science Behind Arthrosamid Injection

Arthrosamid Injection is designed for the symptomatic treatment of knee osteoarthritis and works differently from short-term options because it becomes integrated within the synovial tissue rather than lubricating the joint temporarily. The hydrogel is taken up into the synovial membrane over time, where it may help create a cushioning effect and support joint elasticity in suitable patients. This is described as a gradual physical and biological process rather than an instant effect.

Clinical evidence supporting Arthrosamid includes a published randomised controlled trial comparing it against hyaluronic acid, which found Arthrosamid was non-inferior over 12 months, with clinically meaningful improvements in pain and function. A separate 2025 publication reporting five-year follow-up data from a prospective open-label study found sustained improvements in pain, stiffness, function, and patient global assessment through to five years.

What the Safety Data Actually Shows

The published clinical data reports a generally favourable safety profile. The most commonly reported adverse events were procedure-related, such as temporary pain or swelling. In the five-year extension study, no serious events were attributed to the device itself, and no new adverse device effects were reported. This matters directly for the infection question: long-term studies have not flagged infection as a recurring complication in properly conducted trials, though the evidence base remains smaller than for older, more established treatments like steroid injections.

What Arthrosamid Injection Treats

Arthrosamid treats the symptoms of knee osteoarthritis. It is not a cure, and it does not reverse joint damage. For suitable patients, it may reduce pain, ease stiffness, and support better movement. Common symptoms patients raise before treatment include:

  • Persistent knee pain that continues despite rest, medication, or physiotherapy
  • Morning stiffness or stiffness after periods of inactivity
  • Reduced mobility, including difficulty bending, straightening, or climbing stairs
  • Mild to moderate swelling around the knee
  • Pain specifically when bending or straightening the joint
  • Reduced confidence in everyday movement due to anticipated pain

Not all knee pain comes from osteoarthritis, so a proper clinical assessment always comes first.

Who Should Not Have Arthrosamid Because of Infection Risk

This is where infection risk becomes a suitability question rather than an abstract statistic. Arthrosamid is not suitable where there is an active infection in or around the knee joint. Injecting into an already-infected joint risks spreading that infection deeper into the tissue. Patients with a known hypersensitivity to polyacrylamide should also avoid the treatment, and anyone with a history of joint infection, recent knee surgery, or a compromised immune system needs a much closer look before proceeding.

A thorough medical history and physical examination should always happen before this treatment gets anywhere near a consent form.

How Clinics Reduce Joint Infection Risk

Infection prevention is a procedural discipline, not a single step. It runs through the entire pathway, from the room where the injection happens to the follow-up call afterward.

Sterile Technique and Ultrasound Guidance

Ultrasound guidance supports accurate placement of the needle within the joint, reducing repeated attempts and unnecessary tissue disruption. Combined with sterile single-use equipment, this forms the baseline standard for any Arthrosamid procedure.

Antibiotic Prophylaxis

Official product instructions state that prophylactic antibiotics should be given before injection. This single step is one of the clearest, most concrete infection-prevention measures a patient can ask about directly when researching a provider.

Pre-Screening for Active Infection

Confirming there is no active infection in or around the knee, and reviewing the patient’s full medical history, removes one of the biggest preventable risk factors before the needle ever comes out.

Warning Signs to Watch After Treatment

Recovery is generally straightforward, and most patients go home the same day. Mild discomfort, a feeling of fullness, or light swelling in the first few days is normal and does not mean anything has gone wrong. The line between normal recovery and a genuine problem is sharpness and direction of change.

Contact the clinic directly, without waiting for a scheduled follow-up, if any of the following appear:

  • Increasing redness around the knee
  • Warmth that is getting worse rather than settling
  • Fever
  • Pain that is worsening rather than gradually improving

These signs should never be brushed off as “just part of recovery.” Prompt medical attention is the right response every time.

Arthrosamid Injection Cost UK

Cost is one of the most searched questions alongside safety, and it deserves the same transparency. At Dr SNA Clinic in London, pricing is published openly so patients know the cost before booking a consultation:

  • Single knee: £2,800 (reduced from £3,200), including enhanced recovery support with post-injection physiotherapy guidance and supplement advice
  • Both knees: £5,300 (reduced from £6,400), for suitable patients with symptoms affecting both knees following proper assessment and imaging review
  • Consultation fee: £100, redeemable against the treatment cost if the patient proceeds
  • 0% finance available for patients who want to spread the cost

Every treatment package includes a comprehensive consultation with Mr S N Abbas, the ultrasound-guided injection itself, and a follow-up assessment. There is no obligation to proceed after the consultation, and the final treatment cost gets confirmed before any decision is made.

Arthrosamid Injection Near Me: Finding a Properly Regulated Clinic

Searching arthrosamid injection near me returns a mix of providers, and infection risk is exactly where the differences between them show up. A patient comparing options should look for CQC regulation, GMC registration of the treating clinician, and confirmation that the same doctor who assesses suitability also performs the injection.

Dr Syed Nadeem Abbas at Dr SNA Clinic, 48 Wimpole Street, Marylebone, London W1G 8SF, personally performs every Arthrosamid injection at his clinic, from the pre-injection assessment through to the procedure itself. He does not delegate the treatment. Mr Abbas holds MBBS, MRCSEd (Royal College of Surgeons of Edinburgh, 2006), and an MSc with Distinction from Queen Mary University of London, and he completed specialist Arthrosamid training through the American Cellular Medical Association. His background includes over six years in Trauma and Orthopaedics at NHS hospitals including Cambridge and Oxford.

The clinic is CQC-regulated (Provider ID 1-17192425054, registered 18 June 2024) and Mr Abbas is GMC registered (No. 6026154). Every procedure uses sterile single-use equipment, and the full risks and benefits get discussed at consultation before treatment is agreed.

Clinic hours run 10:00 to 18:00 UK time. Patients can book a consultation through the clinic’s booking page or reach the team on the primary line at +44 7955 836986 or the office line at +44 20 3846 7111.

How Arthrosamid Compares to Other Knee Injections

TreatmentDurationInfection-Related Notes
ArthrosamidUp to 5 years in published follow-up studiesSingle injection; antibiotic prophylaxis recommended before treatment
Steroid InjectionAround 2 to 10 weeksRepeated injections mean repeated exposure points
Hyaluronic AcidMonths, variableNot currently recommended by NICE for osteoarthritis management
PRP InjectionVariableNICE notes evidence on efficacy is limited in quality
Knee Replacement15 to 20 years typicallySurgical infection risk is a separate, more significant consideration

Every option carries some level of procedural risk. The right choice depends on individual clinical assessment, not a table alone.

What to Ask at Consultation

A consultation is the natural point to raise infection questions directly, and a good clinician will welcome them rather than deflect. Useful questions include:

  1. Is the injection given under real-time ultrasound guidance?
  2. Will antibiotics be given before the procedure?
  3. Who performs the injection, and is it the same person who assessed suitability?
  4. What should I do if I notice redness, warmth, or fever afterward?
  5. Is the clinic CQC regulated, and is the treating doctor GMC registered?

Patients researching this treatment often find it helpful to watch a clinician explain the mechanism directly rather than read about it secondhand. Dr SNA Clinic’s YouTube channel includes a video walkthrough of how Arthrosamid works, presented by Mr Abbas himself, alongside a wider series on knee osteoarthritis and synovitis.

Frequently Asked Questions

Is joint infection common after Arthrosamid injection?

No. It is classed as a rare but serious risk, not a common side effect. Common side effects are mild pain, swelling, and temporary stiffness that settle within days.

Why do doctors give antibiotics before Arthrosamid?

Because the hydrogel is non-biodegradable and remains in the joint long-term, official product instructions recommend prophylactic antibiotics as a standard precaution against infection.

Can I have Arthrosamid if I have an active infection somewhere else in my body?

This should always be discussed at consultation. An active knee joint infection rules out treatment entirely, and other active infections need individual clinical review.

What should I do if my knee gets worse instead of better after treatment?

Contact the clinic directly and do not wait for your scheduled follow-up. Worsening pain, redness, warmth, or fever need prompt medical attention.

How much does Arthrosamid injection cost in the UK?

At Dr SNA Clinic, a single knee costs £2,800 and both knees cost £5,300, with a £100 consultation fee redeemable against treatment.

Final Thought

Infection risk with Arthrosamid is real but rare, and it responds directly to how carefully a clinic manages the procedure. Ultrasound guidance, antibiotic prophylaxis, sterile technique, and honest pre-screening are not marketing points — they are the specific practices that keep this risk low. Patients researching Arthrosamid and joint infection deserve a provider who discusses this openly at consultation rather than one who avoids the topic. A conversation with a properly regulated, experienced clinician remains the safest first step before any decision gets made.

Related Reading From Dr SNA Clinic

Mr Syed Nadeem Abbas, MBBS, MRCSEd, MSc Aesthetic Plastic Surgery (Distinction) Medical Director, Dr SNA Clinic 48 Wimpole Street, Marylebone, London W1G 8SF GMC Registered | CQC Regulated | Monday to Saturday 10:00–18:00 +44 7955 836986 | info@drsnaclinic.com

Trusted by patients across the UK